The ability of lomefloxacin to penetrate and distribute within the human prostate was assessed in 20 patients undergoing elective prostate surgery (18 transurethral prostatic resections and 2 prostatectomies). Subjects were middle-aged to elderly (mean age ± standard deviation, 69.8 ± 8.2 years) with normal hepatic function and with creatinine clearances ranging from 35.8 to 141 ml/min/1.73 M2. Lomefloxacin was administered in 400-mg doses orally every 24 h. Its disposition was characterized following the third dose by obtaining multiple serum samples and intraoperative paired central zone and peripheral zone prostate tissue samples. Lomefloxacin concentrations were determined by a validated high-performance liquid chromatography method with fluorescence detection. Concentrations in serum during the perioperative period declined from 3.1 + 1.0 mg/liter (mean ± standard deviation) at 1 h postdose to 2.3 ± 0.7 mg/liter at 6 h postdose. The time of tissue extraction ranged from 0.1 to 7.1 h postdose. Intraoperative serum lomefloxacin concentrations ranged from 0.5 to 4.8 (median, 2.4) mg/liter, while prostate tissue concentrations ranged from 1.1 to 10.1 (median, 5.4) mg/kg of tissue for the central zone and 0.9 to 6.5 (median, 5.2) mg/kg for the peripheral zone. Intraindividual paired prostate concentrations (central zone versus peripheral zone) were not statistically different. The partition coefficient (ratio of concentration in prostate to concentration in serum) for the central zone was 2.2 +-0.6 (range, 1.2 to 3.1), and for the peripheral zone it was 2.1 + 0.7 (range, 1.2 to 4.2). Lomefloxacin exhibited good penetration into the human prostate with homogeneous intraprostatic distribution following multiple-dose administration.
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Desirable properties of an antibiotic for the treatment of bacterial prostatitis or for prophylaxis during prostate surgery include a suitable spectrum against prostatic pathogens and the ability to penetrate into the prostate gland. While Escherichia coli and other enteric gram-negative organisms represent the most common isolates, gram-positive cocci are also frequently encountered (7, 8, 14) . Several investigators have demonstrated that lomefloxacin is active against the majority of these organisms in vitro at clinically achievable concentrations in serum (3, 5, 9, 18) . Only one study to date, however, has assessed the concentrations achieved in prostate tissue following a a single dose (Y. Nasi, M. Kishi, H. Kumon, and H. Ohmari, Proc. 15th Int. Congr. Chemother., 1987 ). An additional consideration for the treatment of chronic bacterial prostatitis is that the nidus of infection more frequently resides in the peripheral zone (12) . Despite its apparent clinical relevance, however, the distribution of fluoroquinolones within the prostate has rarely been addressed in pharmacokinetic studies. This investigation was therefore designed to (i) assess intraoperative lomefloxacin prostate tissue concentrations with respect to the profile of the perioperative concentrations in serum following multiple-dose administration, (ii) determine the distribution coefficient of lomefloxacin between serum and prostate tissue, and (iii) quantify and compare central zone and peripheral zone prostate tissue lomefloxacin concentrations.
MATERIALS AND METHODS
Patients. Adult males undergoing elective transurethral prostate resection or prostatectomy at the University Hos-* Corresponding author.
pital, Utrecht, The Netherlands, were enrolled after granting informed consent. The investigational protocol was approved by the institutional Medical Ethics Committee. Patients were excluded if they were hypersensitive to quinolones, had renal impairment (serum creatinine greater than 2.3 mg/dl), had hepatic impairment (alanine aminotransferase, aspartate aminotransferase, or bilirubin greater than twice the upper limit of the normal range), had history of a convulsive disorder, or were receiving mineral antacid therapy.
Study design and serum sampling. A medical history, physical examination, and laboratory screening profile (hematology, serum chemistry, and urinalysis) were completed for each patient before participation in the study. A 24-h urine specimen was also obtained for the determination of creatinine clearance. The laboratory screening profile was repeated within 48 h of study conclusion.
Lomefloxacin was supplied as 200-mg capsules by G. D. Searle Nederland, B.V., Maarssen, The Netherlands. Each subject received 400 mg of lomefloxacin orally every 24 h, beginning 2 days prior to surgery. Patients fasted from the evening before surgery (day 2) until after the operation (day 3) . The morning of the scheduled surgery, the third lomefloxacin dose was consumed with a minimum of water, and multiple blood samples (5 ml each) were The serum lomefloxacin concentration-time profile on the day of surgery for all patients is shown in Fig. 1 respectively (Fig. 2) . The slopes of the regression equations were not significantly different (F = 0.2713). Furthermore, intraindividual paired central and peripheral tissue concentrations (5.1 ± 2.2 versus 4.5 + 1.5 mg/liter) did not significantly differ (Fig. 3) . The mean lomefloxacin partition coefficient for the central zone was 2.2 ± 0.6 (range, 1.2 to 3.1), and for the peripheral zone it was 2.1 ± 0.7 (range, 1.2 to 4.2). imately 10% bound to plasma proteins (data on file, Searle). These properties together with its low percent ionization at physiologic pH theoretically favor tissue and cellular penetration (15, 16) . Furthermore, on the basis of its dissociation coefficients (pKa1, 5.99; pKa2, 9.01), ion trapping may occur for drug gaining access to alkaline prostatic fluids.
DISCUSSION
Following multiple oral administrations of lomefloxacin to patients scheduled for elective prostate surgery, concentrations in serum during the perioperative period (1 to 6 h postdose) exhibited a gradual decline, consistent with the prolonged elimination half-life (approximately 7 h) previously reported from healthy-volunteer studies (11, 13, 17 15 patients with benign prostatic hyperplasia prior to surgery, partition coefficients ranged from 1.0 to 2.8 over a 6-h period. The results of the present multiple-dose investigation are in general agreement with this preliminary study and with published data for other fluoroquinolones, for which prostate partition coefficients ranged from 0.5 to 6 (2) .
In addition to the histological differences which distinguish central and peripheral zones within the prostate gland, the latter region assumes clinical significance in that it is more frequently the site of infection in bacterial prostatitis (12) . The distribution of lomefloxacin within the prostate was therefore assessed in these patients. The majority of subjects (13 of 18) from whom paired prostate tissue samples for both central and peripheral zones were obtained demonstrated a higher central zone concentration (Fig. 3) . Intraindividual paired central and peripheral lomefloxacin concentrations, however, were not statistically different, nor were the relationships correlating the tissue concentrations with those in serum. Lomefloxacin therefore appears to distribute homogeneously throughout the prostate gland to both regions.
